GlobeNewsWire · SPRC · October 22, 2026

SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome

Get the app for more

Explore stock news, insights and company research.